HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takuya Nagano Selected Research
Takuya Nagano Research Topics
Disease
32
Hepatocellular Carcinoma (Hepatoma)
10/2022 - 12/2013
6
Neoplasms (Cancer)
01/2022 - 10/2010
4
Liver Neoplasms (Liver Cancer)
08/2021 - 01/2019
4
Chronic Hepatitis C
08/2019 - 12/2013
3
Fatigue
06/2022 - 01/2022
3
Liver Diseases (Liver Disease)
05/2021 - 03/2020
2
Ascites
05/2022 - 04/2021
2
Hypertension (High Blood Pressure)
03/2022 - 01/2022
2
Neoplasm Metastasis (Metastasis)
01/2022 - 04/2021
2
Infections
03/2020 - 08/2019
1
Carcinoma (Carcinomatosis)
09/2022
1
Hypothyroidism
06/2022
1
Diarrhea
06/2022
1
Edema (Dropsy)
05/2022
1
Sarcopenia
07/2021
1
Disease Progression
07/2021
1
Hemorrhage
04/2021
1
Alcoholic Fatty Liver
01/2021
1
Non-alcoholic Fatty Liver Disease
01/2021
1
Hand-Foot Syndrome
01/2017
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2016
1
Liver Abscess
08/2016
1
Hemolytic-Uremic Syndrome
10/2010
1
Thrombocytopenia (Thrombopenia)
10/2010
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2010
1
Hemolytic Anemia
10/2010
1
Fibrosis (Cirrhosis)
07/2008
Drug/Important Bio-Agent (IBA)
19
lenvatinib
IBA
06/2022 - 01/2019
8
atezolizumab
IBA
10/2022 - 01/2022
8
Bevacizumab (Avastin)
FDA Link
10/2022 - 01/2022
7
Albumins
IBA
01/2022 - 01/2019
6
Bilirubin
IBA
01/2022 - 01/2019
5
Proteins (Proteins, Gene)
FDA Link
05/2022 - 12/2013
4
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
10/2022 - 04/2021
4
Interferons
IBA
03/2020 - 12/2013
3
C-Reactive Protein
IBA
10/2022 - 01/2022
3
Antiviral Agents (Antivirals)
IBA
05/2021 - 12/2013
3
Tyrosine Kinase Inhibitors
IBA
12/2020 - 01/2019
2
Serum Albumin
IBA
01/2022 - 08/2021
2
Sorafenib (BAY 43-9006)
FDA Link
08/2021 - 01/2017
2
Phospholipases (Phospholipase)
IBA
01/2014 - 12/2013
1
Urea (Carbamide)
FDA Link
Generic
05/2022
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2022
1
acarboxyprothrombin (PIVKA)
IBA
01/2022
1
regorafenib
IBA
08/2021
1
Ramucirumab
IBA
04/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Fetal Proteins (Fetoprotein)
IBA
01/2021
1
daclatasvir
IBA
08/2019
1
8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamide
IBA
08/2019
1
asunaprevir
IBA
08/2019
1
Biological Products
IBA
08/2016
1
Iron
IBA
03/2016
1
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2014
1
LDL Receptors (LDL Receptor)
IBA
01/2014
1
Gemcitabine
FDA Link
10/2010
1
Immunoglobulin A (IgA)
IBA
07/2008
1
Alanine Transaminase (SGPT)
IBA
07/2008
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
07/2008
Therapy/Procedure
14
Therapeutics
06/2022 - 12/2013
1
Immunotherapy
10/2022
1
Radiotherapy
05/2019
1
Splenectomy
10/2010
1
Adjuvant Chemotherapy
10/2010
1
Pancreatectomy
10/2010
1
Drug Therapy (Chemotherapy)
10/2010